全文获取类型
收费全文 | 21392篇 |
免费 | 1639篇 |
国内免费 | 607篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 1373篇 |
妇产科学 | 112篇 |
基础医学 | 1876篇 |
口腔科学 | 98篇 |
临床医学 | 2126篇 |
内科学 | 3071篇 |
皮肤病学 | 371篇 |
神经病学 | 232篇 |
特种医学 | 898篇 |
外科学 | 7986篇 |
综合类 | 2020篇 |
预防医学 | 721篇 |
眼科学 | 99篇 |
药学 | 1143篇 |
5篇 | |
中国医学 | 772篇 |
肿瘤学 | 685篇 |
出版年
2024年 | 30篇 |
2023年 | 410篇 |
2022年 | 575篇 |
2021年 | 768篇 |
2020年 | 886篇 |
2019年 | 891篇 |
2018年 | 884篇 |
2017年 | 822篇 |
2016年 | 784篇 |
2015年 | 708篇 |
2014年 | 1278篇 |
2013年 | 1334篇 |
2012年 | 1163篇 |
2011年 | 1297篇 |
2010年 | 1153篇 |
2009年 | 1152篇 |
2008年 | 1055篇 |
2007年 | 949篇 |
2006年 | 987篇 |
2005年 | 879篇 |
2004年 | 730篇 |
2003年 | 615篇 |
2002年 | 520篇 |
2001年 | 450篇 |
2000年 | 440篇 |
1999年 | 328篇 |
1998年 | 283篇 |
1997年 | 229篇 |
1996年 | 230篇 |
1995年 | 229篇 |
1994年 | 213篇 |
1993年 | 155篇 |
1992年 | 177篇 |
1991年 | 107篇 |
1990年 | 94篇 |
1989年 | 88篇 |
1988年 | 91篇 |
1987年 | 91篇 |
1986年 | 71篇 |
1985年 | 74篇 |
1984年 | 47篇 |
1983年 | 30篇 |
1982年 | 50篇 |
1981年 | 30篇 |
1980年 | 35篇 |
1979年 | 29篇 |
1978年 | 26篇 |
1977年 | 24篇 |
1976年 | 26篇 |
1974年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
目的:探讨肾移植术后发生高尿酸血症的机制及防治策略。方法:分析480例肾移植术后患者的临床资料。结果:肾移植术后移植肾功能正常而血尿酸增高者43例(9%),其中痛风7例,移植肾肾盂或输尿管结石3例。随访1~5年,1例痛风患者血尿酸及症状控制不理想,余血尿酸均控制在正常水平,未见并发症的发生。结论:高尿酸血症是肾移植术后较常见的问题,发生原因较多,但主要与环孢素A的作用有关;长期降尿酸及碱化尿液治疗安全、有效。 相似文献
42.
肾移植术后肺部真菌感染的诊治 总被引:8,自引:0,他引:8
目的 探讨肾移植术后肺部真菌感染的诊断与治疗。 方法 回顾性分析 4 3例肾移植术后肺部真菌感染患者的临床资料。男 35例 ,女 8例 ,平均年龄 32岁。发病时间平均为术后 5 9d。 结果 4 3例患者中 ,白色念珠菌 16例 ,克柔念珠菌 4例 ,近平滑念珠菌 2例 ,曲霉菌 4例 ,毛霉菌 3例 ,新型隐球菌 1例 ,奴卡菌 2例 ,其中 14例有细菌、巨细胞病毒混合感染。 11例培养阴性。氟康唑10 0mg/次 ,3次 /d ,连续 10d ,治愈 2 3例 ;两性霉素B脂质体 5 0mg/d ,连续 10d ,治愈 17例 ;死亡 3例。 结论 肺部真菌感染是肾移植术后的严重并发症 ,死亡率高。早期诊断与治疗效果良好。 相似文献
43.
目的 探讨肾小球疾病免疫球蛋白、补体水平与免疫病理的相关性.方法 112 例肾小球疾病患者,14 例健康人测定血清免疫球蛋白及补体,112 例肾小球疾病患者,112 例患者行肾活组织病理检查.结果 112 例肾小球疾病患者 IgG 升高 11 例(9.82%),降低 29 例(25.89%),IgA 升高 33 例(29.46%),降低 2 例(1.79%).IgM 升高 7 例(6.25%),降低 3 例(2.68%),三种免疫球蛋白的变化有显著差异(x2=70.587,P=O.000);C3 减低 29 例(25.89%),C4减低 32 例(28.57%),两者比较无显著差异(X2=0.203,P=0.653).免疫荧光阳性率依次为C3(50%)>lgA(49.11%)>IgG(40.18%)>lgM(21.43%)>C4(14.29%)(x2=49.303,P=0.000);免疫荧光 IgA 阳性者血清 lgA 水平较阴性者高(P=0.042),C3、CA阳性者血清 C3、c4 水平较阴性者低(P=0,P=0.007),IgG、IgM 阳性者血清 IgG、lgM 水平与阴性者比较无差异(P=0.136,P=0.383).结论 肾小球疾病存在体液免疫紊乱,测定血清免疫球蛋白、补体及行肾组织免疫病检有助于了解体液免疫状况,估计疾病活动度,判断疗效,但两种检查之间无明显的相关性,可相互补充,不能相互替代. 相似文献
44.
过量氟对大鼠肾组织骨桥蛋白表达的影响 总被引:2,自引:0,他引:2
目的检测骨桥蛋白(OPN)mRNA和蛋白在氟处理大鼠肾组织中的表达差异和蛋白定位,并探讨OPN与氟中毒肾损害的关系。方法经饮水投氟喂养Wistar大鼠48只,用免疫组织化学法进行骨桥蛋白的组织学检测。提取各组大鼠肾组织mRNA,采用RT-PCR法检测骨桥蛋白mRNA的表达变化。结果免疫组织化学结果表明,骨桥蛋白主要定位于肾组织的肾小管上皮细胞质中,常食和偏食对照组大鼠肾组织OPN蛋白只是散在表达,而常食和偏食加氟组的OPN蛋白表达较相应对照组明显增强(与常食对照组比较,q=18.4,P< 0.05;与偏食对照组比较,q=12.0,P<0.01)。2个投氟组的OPN mRNA表达水平均较相对应的对照组增加,但差异无统计学意义。结论过量氟可促进大鼠。肾组织OPN表达,且随着投氟量的增加,OPN伴随着肾损伤加重而表达增强,提示OPN与氟中毒肾损伤程度密切相关,很可能作为一种氟中毒肾损害的预测标志。 相似文献
45.
采用DNA聚合酶链反应-单链构象多态性分析和直接序列测定技术,检测25例肾细胞癌组织中P53基因5-8外显子,25例肾细胞癌仅有2例肿瘤组织存在P53基因点突变,分别位于154和273密码子上,核苷酸序理分析突变形式分别为G→T,C→T。结果提示:肾细胞癌组织中P53基因突变并不显著,表明肾细胞癌的发生可能是一个多基因变化的过程。 相似文献
46.
50岁以上肾移植的临床分析 总被引:2,自引:0,他引:2
自1989年1月~1995年12月共施行同种异体尸肾移植术556例次,其中50岁以上患者182例(327%),对这些患者的临床资料进行比较分析。结果显示:50岁以上组1、3、5年的人/肾存活率分别为834%/793%、771%/711%和545%/455%,与49岁以下组比较差异无显著性(P>005),急性排斥发生率并不比49岁以下组高,并发症发生率尤其是感染发生率及致死率均高于49岁以下组(P<005)。本资料说明,年龄不是肾移植的主要影响因素,感染和心血管并发症是主要的死亡原因和影响长期存活的因素。适应证的选择和术前充分透析,术后合理应用免疫抑制剂,定期复查及心、肝、肺功能的监护,是提高高龄肾移植患者长期存活的主要因素。 相似文献
47.
P. Peeters J. Sennesael H. De Raeve M. De Waele D. Verbeelen 《Transplant international》1997,10(6):471-474
Lymphoma in immunocompromised transplant patients is a feared cause of morbidity and mortality. Superimposed on the lymphoma
and the transplantation immunosuppression is a rare condition: hemophagocytic syndrome (HS). HS is characterized by fever,
hepatosplenomegaly and lymphadenopathy, skin rashes, jaundice, coagulopathy, and phagocytosis of blood elements with pancytopenia.
Here we describe a rare but fatal case of a kidney transplant patient who developed T-cell lymphoma and HS, without evidence
of EBV replication. A short review of the diagnosis, treatment, and prognosis of HS is given.
Received: 4 March 1997 Received after revision: 6 June 1997 Accepted: 30 June 1997 相似文献
48.
Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants 总被引:2,自引:0,他引:2
Yu Seun Kim Myoung Soo Kim Soon Il Kim Seung Kil Lim Ho Yung Lee Dae Suk Han Kiil Park 《Transplant international》1997,10(3):197-201
It is well known that long-term use of steroids plays a decisive role in the development of glucose intolerance and diabetes
mellitus (DM). Deflazacort, an oxazoline derivative of prednisolone, has been introduced as a potential substitute for conventional
steroids in order to ameliorate glucose intolerance. We initiated a randomized study of conversion from prednisone to deflazacort
in kidney transplantation (Tx) recipients presenting with pre-Tx or post-Tx DM to ascertain whether or not the switch to deflazacort
would ameliorate the diabetic state. Forty-two recipients in the conversion group were compared with 40 patients on prednisone
(the control group) in a prospective manner. The dose reduction of insulin or oral blood glucose-lowering agents, the adequacy
of glucose control, and the development of side effects were the criteria for evaluating outcome. In the conversion group,
patients were switched to deflazacort at a dose ratio of 6 mg deflazacort to 5 mg prednisone. During the mean follow-up period
of 13.2 months, neither graft dysfunction nor acute rejection developed in the conversion group. Improvement in blood glucose
control in the conversion group was noted. When the conversion group was stratified into pre- or post-Tx DM, promising effects
were clearly evident in the post-Tx DM patients. More than 50 % dose reduction of blood glucose-lowering agents was possible
in 42.3 % of post-Tx DM patients. In conclusion, it was readily possible to control blood glucose better in post-Tx DM recipients
without seriously affecting the immunosuppressive activity after conversion to deflazacort.
Received: 20 August 1996 Received after revision: 25 November 1996 Accepted: 6 December 1996 相似文献
49.
At our center, since 1982, a body mass index (BMI) of less than 30 has been a prerequisite for placing a patient on the waiting
list for renal transplantation. This decision was made because obese transplant recipients seemed to have a less than favorable
post-transplant outcome. The aim of this study was to evaluate whether this requirement is still justified. Forty-six patients
with a BMI above 30 underwent primary cadaveric renal transplantation between 1972 and 1993. For each of these obese patients,
five consecutive non-obese (BMI 20–25) control patients were selected. Patient and graft survival, causes of graft loss, and
acute rejection rate were evaluated for the two patient groups before and after the year 1982. Within the first 30 post-transplant
days, one patient (2 %) and 11 grafts (24 %) were lost in the group of obese patients whereas seven patients (3 %) and 36
grafts (16 %) were lost in the control group. Among the obese patients, renal circulatory complications were a major cause
of graft loss. In the period 1973–1981, the 1-year patient survival rate was 65 % among obese patients versus 75 % among controls
from 1982 to 1993, this was 90 % versus 93 %. From 1973 to 1981, the 1-year graft survival rate was 25 % among obese patients
versus 53 % among controls (P < 0.05); from 1982 to 1993, it was 68 % versus 84 % (P = NS). Multivariate analysis showed that the immunosuppressive regimen,
age of the patient, BMI, and cold ischemia time of the graft had a significant influence on graft survival. The acute rejection
rate within the first 30 days was 28 % among obese patients and 35 % among controls (P = NS). We conclude that a BMI below
or equal to 30 is still justified as a prerequisite for placement on the waiting list for renal transplantation, for despite
an overall improvement, the outcome of renal transplantation in obese patients remains worse than that in non-obese patients.
Received: 3 February 1997 Received after revision: 4 April 1997 Accepted: 8 April 1997 相似文献
50.
Tae-Hoon Kim 《Korean journal of radiology》2005,6(3):200-203
Only rarely is renal cell carcinoma encountered in a horseshoe kidney. This is a case report on renal cell carcinoma in a horseshoe kidney, in which superselective renal artery embolization was performed preoperatively. CT and digital subtraction angiography revealed a horseshoe kidney with a 3-cm tumor in the left side. Superselective renal artery embolization of the tumor was performed as a prerequisite procedure for the organ-preserving surgery of simple enucleation. Preoperative superselective renal artery embolization can be an effective tool to facilitate organ-preserving surgery in a horseshoe kidney. 相似文献